Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Desert Gold Report Results from 3,900 Meter Phase 2 Exploration Drill Program (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
ONCY
Primary Symbol:
T.ONC
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and...
adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(117)
•••
spesestsemper
X
View Profile
View Bullboard History
Post by
spesestsemper
on Dec 02, 2024 2:17pm
master protocol
I would hope when they make the announcement in the next little bit about the master protocol ,they take the time and explain what it actually means . What is the scope and depth of it ? Does it mean
...more
(117)
•••
spesestsemper
X
View Profile
View Bullboard History
Post by
spesestsemper
on Dec 02, 2024 1:10pm
pr piece
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend Once the master protocol is finalized with the Global Coalition for Adaptive Research (GCAR), Oncolytics
...more
(95)
•••
Quentin30
X
View Profile
View Bullboard History
Comment by
Quentin30
on Dec 02, 2024 1:09pm
RE:Weekend update , hello all
Interesting tome Canaduh... the PC trial could indeed lead to a partnership,... but it's worth remembering that the oft touted Phase III ready mBC co-therapy, INCLUDES Chemo... and It is likely
...more
(5104)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Dec 01, 2024 6:46pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:Biotech industry readies for " Pharma M&A Spree"
Ken Keller, President and CEO of Daiichi Sankyo, Inc. provides an in-depth look into the company's transformation from a cardiovascular-focused organization to a leader in oncology. The
...more
(215)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Dec 01, 2024 5:08pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:How does Accelerated Approval work
I'm not sure why someone would come to this site and get all emotional and tell their life medical history. THIS IS NOT THE PLACE FOR THAT. I would not want to disclose any personal info here
...more
(215)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Dec 01, 2024 4:26pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:How does Accelerated Approval work
Just because canuckcluck etal has more followers only proves my point of how gullible blind folks are. All anyone has to do is look at the 5 year chart to prove my point. Figures font lie but liars
...more
(5104)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Dec 01, 2024 3:47pm
RE:Roche inks $1.5B Poseida buyout
Leerink Partners is the sole book-runner in Replimmune's US$140 million follow-on raise. https://leerink.com/transactions/
(902)
•••
canadafan
X
View Profile
View Bullboard History
Post by
canadafan
on Dec 01, 2024 2:39pm
Weekend update , hello all
I know there is a core group of visitors to this site. Many resd, few post. FYI, Mr. Buck. My posts get on average 5x to 10x if not more, than your reads. why woukd that be? Talking about telling
...more
(5104)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Dec 01, 2024 1:26pm
RE:RE:RE:RE:RE:RE:RE:RE:Biotech industry readies for " Pharma M&A Spree"
Some bigger deals have been completed this year but none were instances in which a pharma group was buying a biotech to get hold of promising drugs. A tough antitrust environment under Lina
...more
(5104)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Dec 01, 2024 12:32pm
RE:RE:RE:RE:RE:RE:RE:Biotech industry readies for " Pharma M&A Spree"
M&A tends to pick up as company’s approach big Loss of Exclusivity (LOE) events. For Merck, they’re facing a $30B LOE in 2028 with Keytruda and have made big bets on Acceleron ($11.5B
...more
(215)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Nov 29, 2024 7:36pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:How does Accelerated Approval work
We have not seen close to $5 since December 2019... that should speak volumes and tells the true story... not the nake believe world of the forever pumpers.
(5104)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 29, 2024 5:59pm
RE:RE:RE:RE:RE:RE:What's with Morgan Stanley Canada hitting the bid with 100
Recent Trades - Last 10 of 356 Time ET Ex Price Change Volume Buyer Seller Markers 16:00:00
...more
(5104)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 29, 2024 5:54pm
RE:RE:RE:RE:RE:What's with Morgan Stanley Canada hitting the bid with 100
" single target of Non-muscle invasive bladder cancer (NMIBC) "
(5104)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 29, 2024 5:52pm
RE:RE:RE:RE:What's with Morgan Stanley Canada hitting the bid with 100
The OV company CG Oncology with a single target of Non-muscle invasic bladder cancer (NMIBC) has a market ap of US$2.35 Billion at today's close. https://cgoncology.com/pipeline/
(215)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Nov 29, 2024 5:29pm
RE:RE:RE:RE:RE:RE:RE:RE:How does Accelerated Approval work
I think if there was any interest..This stock epuld be around $5 or so..the street has not interest ... which is what keeps it below a buck... pun intended
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Learn How this Company is Disrupting Point-of-Care Testing
Unique Battery Metals opportunity in Quebec
Discover Options Trading Strategies to Minimize your Tax Burden
Debt-Free Cannabis Company Set for Next Stage of Growth
Rig Count Soars as Utilization Surpasses Industry Averages